STAT March 17, 2020
At the stroke of midnight on Tuesday morning, seven counties in the San Francisco Bay Area went into near-lockdown — ushering in a new reality for biopharma companies and biomedical labs.
The “shelter in place” order, which aims to slow the spread of the coronavirus by mostly confining residents to their homes for at least the next three weeks, offers significant leeway for medical research. Employees of pharma and biotech companies are explicitly allowed to travel to and from work. So too is anyone working in “health care operations,” which leaves the door open for clinical trials to continue. Another exception allows university employees to travel to perform “essential functions,” provided they stay 6 feet away from each other —...
Today's Sponsors
Today's Sponsor